Education and Information for OR Decision‑Makers
How awareness evolves to action on surgeon, patient gender gaps
Cardiovascular disease is the leading killer of both women and men, but more women are dying. Why? Evidence points to lack of research and a one-size-fits-all approach to care, including in the OR. “Many of
Learn more »
Trending Aricles of the Week
- Unveiling ECRI’s 2024 Top 10 Patient Safety Concerns list
- Common inspection points for surgical instrumentation
- Keeping it sterile: Fundamentals of sterile storage
- ASC staffing woes persist in era of increased surgical volume
- Antiseptic nasal decolonization noses ahead
Exclusive Content
- Blast from the past: Improving medication safety in the OR
- Perioperative management: Top challenges, priorities for OR leaders in 2024, per survey
- OR Manager Conference third place poster winner showcases impactful program from 2023
- OR Manager Conference second place poster winner showcases impactful program from 2023
- OR Manager Conference first place poster winner showcases impactful program from 2023
Articles
- Antiseptic nasal decolonization noses ahead
- Surgery center culture must prioritize cleaning, hand hygiene
- Built to grow: Key elements of planning a new ASC
- Interview with US News & World Report: The journey to introduce new ambulatory surgery center ranking
- ASC staffing woes persist in era of increased surgical volume
Type 2 diabetes case cured via stem cell therapy, researchers report
A stem cell transplant cured type 2 diabetes in a 59-year-old man who previously needed multiple daily insulin injections, the South China Morning Post reported May 27. The Chinese researchers behind the reported cure published…
Deadline extended; rewards added for Career/Salary survey
Recognizing that perioperative leaders are busy people, we’ve extended the deadline to participate in the annual OR Manager Career/Salary survey—and we’re sweetening the incentives to include a free Premium Subscription to OR Manager. Now…
Class 1 recall announced for ambulatory infusion pump
The US Food and Drug Administration (FDA) has designated OptumHealth Care Solutions’ recall of the Nimbus II ambulatory infusion pumps a class 1, the most severe category indicating risk of serious injury or death. According…
Conferences brought to you by
Conference Coverage
- Help PACU leaders get the recognition they deserve
- Colorectal cancer rates declining in older adults, rising among children, teens
- Special rates extended for OR Manager event, publication subscription
- OR Manager Conference: Lowest rates expire in one week
- Share your expertise! Topics, speakers sought for 2025 ORBMC
Events
Share your news
- Healthcare providers call for universal platform for recall, other supply disruption alerts
- Nurses projected to see greatest increase in hourly wage by 2033, new study finds
- Sonio, AI-powered prenatal ultrasound management solution, announces implementation by Pediatrix MFM Practice
- TPG announces investment in Compass Surgical Partners to fuel growth in ASC joint ventures
Media Kit
